|
|
|
|
|
HONG KONG, July 17, 2009 - (ACN Newswire) - Lijun International Pharmaceutical (Holding) Co., Ltd. ("Lijun International" or the "Company"; stock code: 2005) and its subsidiaries (the "Group") are pleased to announce that the Group's unaudited profit attributable to the shareholders for the six months ended 30 June 2009 (the "Period") is expected to be close to the Group's audited profit attributable to the shareholders of approximately HK$102,106,000 for the year ended 31 December 2008.
Mr. Wu Qin, Chairman of Lijun International said: "Despite the global economic fluctuations in the first half of 2009, we recorded a profit growth during the Period, as we took advantage of the State's medical system reform, the growth in the size of domestic pharmaceutical market and the industry recovery, meanwhile, as market integration and business environment continued to improve, we are able to increase sales volume at relatively stable selling prices and achieve an increase in gross profit margin."
Mr. Wu added that: "Looking into the second half of the year, the Group is to continue to consolidate its leading role of macrolides antibiotics, strengthen intravenous infusion segment, boost the sales of general medicines and privileged brands, speed up the launches and enhance the sales of OTC and healthcare products. The Group will leverage on every chance to strengthen our development by focusing on the response to the new medical reform, keeping our eye on any possible market terminal changes brought by the implementation of the basic medicines system and the new medical reform, consolidating various characteristics of the Group's product as well as adjusting the strategies for both product development and marketing in time."
Contact:
Wonderful Sky Financial Group Limited
Joanne Chan / Miranda Fok / Daisy Sun
Tel: +852 2851 1038
Fax: +852 2815 1352
E-mail: joannechan@wsfg.hk / mirandafok@wsfg.hk / daisysun@wsfg.hk
Topic: Earnings
Source: Lijun International Pharmaceutical
Sectors: Daily Finance, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
